Phillip Eyler - Apr 5, 2024 Form 4 Insider Report for GENTHERM Inc (THRM)

Role
President & CEO, Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Stock symbol
THRM
Transactions as of
Apr 5, 2024
Transactions value $
-$295,121
Form type
4
Date filed
4/8/2024, 04:57 PM
Previous filing
Mar 26, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THRM Common Stock Options Exercise $533K +15K +10.18% $35.50 162K Apr 5, 2024 Direct
transaction THRM Common Stock Sale -$277K -5.05K -3.11% $54.81 157K Apr 5, 2024 Direct F1, F2
transaction THRM Common Stock Sale -$551K -9.95K -6.33% $55.36 147K Apr 5, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRM Option to Purchase Common Stock Options Exercise $0 -15K -12.53% $0.00 105K Apr 5, 2024 Common Stock 15K $35.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2023 that provides for the sale of up to 134,684 shares of common stock upon the exercise of stock options. The stock options were granted by Gentherm on December 4, 2017 and have an expiration date of December 4, 2024.
F2 The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $54.66 to $54.9902. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F3 The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $55.00 to $55.71. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F4 The option is fully vested.